Sciele Pharma, Inc., a pharmaceutical company, engages in the development, marketing, and sale of prescription products for cardiovascular/diabetes diseases and women’s health. The company’s products include Sular, an antihypertensive prescription medication; Fortamet, a type 2 diabetes prescription medication; Altoprev for the treatment of high cholesterol; Triglide, an oral treatment for lipid disorders, such as elevated triglycerides; and Nitrolingual spray for acute relief or prevention of chest pain associated with angina pectoris that results from coronary artery disease. It also offers Prenate Elite and OptiNate, a prescription multivitamin/multimineral nutritional supplement for improving the nutritional status of women throughout pregnancy and in the postnatal period; and Ponstel for the relief of pain for patients and for primary dysmenorrhea, which is pain associated with menstruation. In addition, Sciele Pharma offers Zovirax, used in the treatment of type I (cold sores) and type II (genital) herpes simplex viruses; Ostiva, which offers a nutritional foundation for maintaining bone health; Furadantin for the treatment of urinary tract infections; Cognex for the treatment of mild to moderate dementia associated with Alzheimer’s disease; Robinul and Robinul Forte that belong to a class of drugs known as anticholinergics, which reduce the motion of the gastrointestinal tract and decrease stomach; Zoto-HC ear drops for the treatment of swimmer’s ear infections; and Zebutal capsules for the treatment of tension headaches. The company sells its products to pharmaceutical wholesalers, chain drug stores, other retail merchandisers, and directly to pharmacies. Sciele Pharma was founded in 1992. It was formerly known as First Horizon Pharmaceutical Corporation and changed its name to Sciele Pharma, Inc. in 2006. The company is headquartered in Atlanta, Georgia.